Laron Syndrome Research Paves the Way for New Insights in Oncological Investigation.

Animals Biomedical Research Humans Insulin-Like Growth Factor I / metabolism Intercellular Signaling Peptides and Proteins / metabolism Laron Syndrome / genetics Neoplasms / epidemiology Risk Factors
Laron syndrome cancer protection growth hormone growth hormone receptor insulin-like growth factor-1 (IGF1)

Journal

Cells
ISSN: 2073-4409
Titre abrégé: Cells
Pays: Switzerland
ID NLM: 101600052

Informations de publication

Date de publication:
09 11 2020
Historique:
received: 18 10 2020
revised: 04 11 2020
accepted: 05 11 2020
entrez: 13 11 2020
pubmed: 14 11 2020
medline: 17 6 2021
Statut: epublish

Résumé

Laron syndrome (LS) is a rare genetic endocrinopathy that results from mutation of the growth hormone receptor (

Identifiants

DOI: 10.3390/cells9112446 PMID: 33182502 PMC: PMC7696416
pubmed: 33182502
pii: cells9112446
doi: 10.3390/cells9112446
pmc: PMC7696416
pii:
doi:

Substances chimiques

Intercellular Signaling Peptides and Proteins 0
Insulin-Like Growth Factor I 67763-96-6

Types de publication

Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S. Review

Langues

eng

Sous-ensembles de citation

IM

Références

J Lab Clin Med. 1957 Jun;49(6):825-36
pubmed: 13429201
Eur J Cancer. 2020 Dec;141:115-127
pubmed: 33130549
Nature. 1963 Aug 24;199:784-7
pubmed: 14071191
Antioxid Redox Signal. 2012 Mar 15;16(6):587-96
pubmed: 21929372
Cancer Res. 2000 Sep 15;60(18):5278-83
pubmed: 11016658
Proc Natl Acad Sci U S A. 1999 Jun 22;96(13):7324-9
pubmed: 10377413
Endocrinol Metab Clin North Am. 2012 Jun;41(2):231-47, v
pubmed: 22682628
Isr J Med Sci. 1984 Jan;20(1):8-11
pubmed: 6321400
J Clin Endocrinol Metab. 2008 Nov;93(11):4210-7
pubmed: 18782877
Isr J Med Sci. 1966 Mar-Apr;2(2):152-5
pubmed: 5916640
J Clin Endocrinol Metab. 1973 Nov;37(5):819-21
pubmed: 4795989
Nat Rev Mol Cell Biol. 2015 Jul;16(7):393-405
pubmed: 26122615
Am J Med Genet A. 2014 May;164A(5):1204-8
pubmed: 24664892
Cell Metab. 2020 Sep 1;32(3):353-365.e8
pubmed: 32726606
Acta Endocrinol (Copenh). 1993 Feb;128(2):144-9
pubmed: 7680834
Nat Clin Pract Endocrinol Metab. 2007 Mar;3(3):302-10
pubmed: 17315038
Endocr Relat Cancer. 2016 May;23(5):399-410
pubmed: 27090428
Oncogene. 2000 Nov 20;19(49):5574-81
pubmed: 11114737
Endocr Connect. 2017 Aug;6(6):395-403
pubmed: 28649085
J Natl Cancer Inst. 1999 Apr 7;91(7):620-5
pubmed: 10203281
Eur J Cancer. 2012 Jul;48(10):1570-80
pubmed: 22033326
Science. 2003 Feb 28;299(5611):1342-6
pubmed: 12610293
Pediatr Endocrinol Rev. 2015 Dec;13(2):521-30
pubmed: 26841640
Trends Endocrinol Metab. 1998 Sep;9(7):276-83
pubmed: 18406284
Cell. 1993 Oct 8;75(1):73-82
pubmed: 8402902
Science. 1998 Jan 23;279(5350):563-6
pubmed: 9438850
Oncotarget. 2019 Jul 08;10(43):4437-4448
pubmed: 31320996
Proc Natl Acad Sci U S A. 1997 Nov 25;94(24):13215-20
pubmed: 9371826
Oncology. 2002;63(4):317-32
pubmed: 12417786
Growth Horm IGF Res. 2005 Jul;15 Suppl A:S3-5
pubmed: 16023877
EMBO Mol Med. 2016 Mar 31;8(4):363-74
pubmed: 26902202
Endocr Pract. 2015 Dec;21(12):1395-402
pubmed: 26401581
Cells. 2019 Oct 06;8(10):
pubmed: 31590432
Oncogene. 2007 Mar 15;26(12):1811-9
pubmed: 16983336
J Biol Chem. 2013 Mar 8;288(10):6835-48
pubmed: 23329835
Cell. 2009 Jun 12;137(6):1001-4
pubmed: 19524504
Endocrinology. 2005 Dec;146(12):5188-96
pubmed: 16141391
Eur J Clin Invest. 1998 Jan;28(1):41-7
pubmed: 9502186
Mol Genet Metab. 2000 Sep-Oct;71(1-2):315-20
pubmed: 11001824
J Clin Endocrinol Metab. 1992 Apr;74(4):743-50
pubmed: 1372321
BMC Cancer. 2013 Nov 22;13:556
pubmed: 24267955
Cancer Res. 1995 Sep 1;55(17):3739-41
pubmed: 7641185
Acta Paediatr. 2000 Jan;89(1):38-41
pubmed: 10677055
J Endocrinol. 1999 Sep;162(3):321-30
pubmed: 10467223
Growth Horm IGF Res. 2018 Apr;39:6-12
pubmed: 29208357
Endocrinology. 2014 May;155(5):1793-805
pubmed: 24517230
Carcinogenesis. 2011 Jul;32(7):955-63
pubmed: 21317301
N Engl J Med. 2003 Sep 18;349(12):1139-47
pubmed: 13679528
J Immunol. 2000 Jun 15;164(12):6287-95
pubmed: 10843682
Pharmacogenomics. 2010 Mar;11(3):327-40
pubmed: 20235789
Lancet. 1998 May 9;351(9113):1393-6
pubmed: 9593409
J Clin Endocrinol Metab. 1997 Feb;82(2):629-33
pubmed: 9024266
Proc Natl Acad Sci U S A. 2003 Jul 8;100(14):8247-52
pubmed: 12821780
Clin Cancer Res. 2008 Oct 15;14(20):6364-70
pubmed: 18927274
Cell. 1993 Oct 8;75(1):59-72
pubmed: 8402901
Mol Cell Endocrinol. 2006 Jun 27;252(1-2):241-6
pubmed: 16647191
J Clin Endocrinol Metab. 2004 Mar;89(3):1031-44
pubmed: 15001582
Pediatr Endocrinol Rev. 2004 Jun;1(4):352-60
pubmed: 16437028
Pediatr Endocrinol Rev. 2018 Sep;16(Suppl 1):39-62
pubmed: 30378782
Proc Natl Acad Sci U S A. 1989 Oct;86(20):8083-7
pubmed: 2813379
Pediatr Endocrinol Rev. 2006 Aug;3 Suppl 3:489-97
pubmed: 17551471
Trends Endocrinol Metab. 2008 Aug;19(6):197-205
pubmed: 18515143
Eur J Endocrinol. 2011 Apr;164(4):485-9
pubmed: 21292919
Proc Natl Acad Sci U S A. 1992 May 1;89(9):3889-93
pubmed: 1570309
Biochim Biophys Acta. 1994 Sep 13;1219(1):26-32
pubmed: 8086474
Front Oncol. 2016 Jun 23;6:159
pubmed: 27446805
Autophagy. 2007 Nov-Dec;3(6):542-5
pubmed: 17611390
Proc Natl Acad Sci U S A. 2018 Jan 30;115(5):1045-1050
pubmed: 29339473
Hum Immunol. 2005 Feb;66(2):95-103
pubmed: 15694994
Nat Rev Cancer. 2014 May;14(5):329-41
pubmed: 24722429
J Biol Chem. 2006 Aug 4;281(31):21884-91
pubmed: 16766796
Cancer Res. 2008 May 15;68(10):3680-8
pubmed: 18483250
Oncotarget. 2017 Jun 1;8(37):60826-60840
pubmed: 28977828
N Engl J Med. 1996 Oct 31;335(18):1363-7
pubmed: 8857020
Dev Biol. 2001 Jan 1;229(1):141-62
pubmed: 11133160
Horm Metab Res. 2003 Nov-Dec;35(11-12):758-62
pubmed: 14710355
Curr Pharm Des. 2016;22(39):5948-5961
pubmed: 27412171
J Clin Endocrinol Metab. 1992 Jan;74(1):56-63
pubmed: 1370165
J Clin Endocrinol Metab. 2001 Apr;86(4):1504-10
pubmed: 11297575
Oncogene. 2012 May 31;31(22):2703-14
pubmed: 21963847
Sci Transl Med. 2011 Feb 16;3(70):70ra13
pubmed: 21325617
Growth Horm IGF Res. 2007 Feb;17(1):54-7
pubmed: 17166755
Isr Med Assoc J. 2017 Jan;19(1):6-7
pubmed: 28457105
Growth Horm IGF Res. 2005 Dec;15(6):388-96
pubmed: 16181796
Proc Natl Acad Sci U S A. 1996 Aug 6;93(16):8318-23
pubmed: 8710868
Nat Rev Cancer. 2014 May;14(5):359-70
pubmed: 24739573
Am J Respir Cell Mol Biol. 2009 Aug;41(2):179-88
pubmed: 19131643
N Engl J Med. 1989 Oct 12;321(15):989-95
pubmed: 2779634
EMBO Mol Med. 2017 Oct;9(10):1338-1345
pubmed: 28801361
Endocr Rev. 1994 Jun;15(3):369-90
pubmed: 8076588
Biochem Pharmacol. 2018 Oct;156:32-42
pubmed: 30086285
J Biol Chem. 2002 May 3;277(18):15600-6
pubmed: 11877395
J Mol Endocrinol. 2018 Jul;61(1):T45-T60
pubmed: 29273680
Science. 1990 Aug 31;249(4972):1007-11
pubmed: 2204108
Antioxid Redox Signal. 2000 Spring;2(1):83-92
pubmed: 11232604
Int J Cancer. 2003 Dec 20;107(6):873-7
pubmed: 14601044
Arch Physiol Biochem. 2009 May;115(2):58-71
pubmed: 19485702
N Engl J Med. 2004 Feb 5;350(6):570-7
pubmed: 14762184

Auteurs

Haim Werner (H)

Department of Human Molecular Genetics and Biochemistry, Sackler School of Medicine, Tel Aviv University, Tel Aviv 69978, Israel.
Shalom and Varda Yoran Institute for Human Genome Research, Tel Aviv University, Tel Aviv 69978, Israel.
ORCID: 0000-0003-0154-1290

Rive Sarfstein (R)

Department of Human Molecular Genetics and Biochemistry, Sackler School of Medicine, Tel Aviv University, Tel Aviv 69978, Israel.

Karthik Nagaraj (K)

Department of Human Molecular Genetics and Biochemistry, Sackler School of Medicine, Tel Aviv University, Tel Aviv 69978, Israel.

Zvi Laron (Z)

Endocrine and Diabetes Research Unit, Schneider Children's Medical Center, Petah Tikva 49292, Israel.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Eucaryotes › Animaux › Laron Syndrome Research Paves the Way for New...
questionsmedicales.fr › Disciplines des sciences naturelles › Science › Recherche › Recherche biomédicale › Laron Syndrome Research Paves the Way for New...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Laron Syndrome Research Paves the Way for New...
questionsmedicales.fr › Facteurs biologiques › Protéines et peptides de signalisation intercellulaire › Somatomédines › Facteur de croissance IGF-I › Laron Syndrome Research Paves the Way for New...
questionsmedicales.fr › Facteurs biologiques › Protéines et peptides de signalisation intercellulaire › Laron Syndrome Research Paves the Way for New...
questionsmedicales.fr › Maladies endocriniennes › Nanisme › Syndrome de Laron › Laron Syndrome Research Paves the Way for New...
questionsmedicales.fr › Tumeurs › Laron Syndrome Research Paves the Way for New...
questionsmedicales.fr › Environnement et santé publique › Santé publique › Méthodes épidémiologiques › Statistiques comme sujet › Probabilité › Risque › Facteurs de risque › Laron Syndrome Research Paves the Way for New...